Assisted Reproductive Technology Market Trends 2021 By Top Players Cooper Companies Inc., Genea Limited, laboratoire CCD and Vitrolife AB

Rising infertility in men and women due to lifestyle choices, ageing, unhealth eating habits, smoking, and other factors has shifted focus towards the adoption of assisted reproductive technologies. Ovulation induction, in-vitro fertilization, gamete intrafallopian transfer and artificial insemination are some of the technologies that come under assisted reproduction.

According to Centers for Disease Control and Prevention, around 306,174 assisted reproductive technology cycles were performed within fertility clinics across the U.S. in 2018. On the overall level around 1.9% infants were born using ART in 2018 in the U.S. Growing awareness pertaining these treatment and therapies for infertility will encourage more people to opt for it.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/506

Moreover, increasing acceptance of novel reproduction methods in developing countries will positively impact industry growth in the coming years. In 2019, assisted reproductive technology market size recorded at USD 26 billion globally in terms of revenue and is estimated to exhibit a CAGR of 4.4%% through 2026. Increasing prevalence of infertility among working women will majorly encourage adoption of these technologies.

Several government and private organizations are undertaking initiatives to create awareness about reproductive technologies. Rising awareness pertaining to reproductive technologies will create favorable scenario for adoption for ART. In addition, technological advancement which brings reliability will further propel the demand for ART in the coming years.

In 2019, frozen nondonor procedure segment accounted for USD 8.5 billion in terms of revenue. As compared to other procedures, the number of frozen nondonor egg implantations are rising. According to the CDC, maximum frozen nondonor embryo implantations were reported within young aged women across U.S. in 2015.

AI-IUI procedure is affordable and less invasive and is commonly recommended by doctors during beginning of infertility treatment. In 2019, artificial insemination-intrauterine insemination industry held 20% of the total revenue share of the market. The procedure is gaining major attention from couples with unexplained fertility as well as male fertility issues. Various benefits associated with AI-IUI technology will foster segment size over the analysis period.

Customer preference for hospitals is high owing to the availability of skilled professionals and developed facilities. Access to experienced gynecologists and advanced equipment with will drive hospital segment growth. ART industry share from the hospitals segment is estimated to register a CAGR of 4.7% CAGR between 2020-2026.

The U.S. ART market in 2019 generated a revenue of over USD 7.5 billion and is likely to grow at significant rate owing to growing prevalence of infertility. Increasing incidence of adoption of unhealthy habits, obesity, smoking, PCOD are leading to infertility and may boost the adoption of assisted reproductive technology in the region.

Key players operating in the assisted reproductive technology industry include Genea Limited, The Cooper Companies Inc., Vitrolife AB and Laboratoire CCD, among others.

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/assisted-reproductive-technology-market

Partial Chapter of the Table of Content

Chapter 2. Executive Summary

2.1. Assisted reproductive technology Market industry360° synopsis, 2015 – 2026

2.1.1. Business trends

2.1.2. Procedure trends

2.1.3. Technology trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Assisted Reproductive Technology Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Rising prevalence of infertility

3.3.1.2. Demographical shift

3.3.1.3. Rising awareness about assisted reproductive technology

3.3.2. Industry pitfalls and challenges

3.3.2.1. High cost of procedures

3.3.2.2. Social barriers and lack of advanced infrastructure in emerging countries

3.4. Growth potential analysis

3.4.1. By procedure

3.4.2. By technology

3.4.3. By end-use

3.5. COVID-19 impact analysis

3.6. Porter’s analysis

3.7. Competitive landscape, 2019

3.7.1. Strategy dashboard, 2019

3.8. PESTEL analysis

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.